Skip to main content

Table 1 Summary of three randomized controlled trials included in the meta-analysis

From: Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis

Study

Publication year

Stage

CT regimen

CRT regimen

Number of patients

Median survival

CT

CRT

CT

CRT

Girard et al.

2010

cN2 IIIA

GC

VP or PC + Con RT(46Gy)

14

32

24.2

Katakami et al.

2012

pN2 IIIA

DC

DC + Con RT(40Gy)

28

28

29.9

39.6

Pless et al.

2015

pN2 IIIA

DP

DP + Seq RT(44Gy)

115

117

26.2

31.7

  1. Abbreviations: GC gemcitabine + cisplatin, DP docetaxel + cisplatin, DC docetaxel + carboplatin, VP vinorelbine + cisplatin, PC paclitaxel + carboplatin, Seq RT sequential radiochemotherapy, Con RT concomitant radiochemotherapy